Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

JDOC vs. RYHIX: which is better?

Bottom line

JDOC vs RYHIX: the short answer

JDOC (JPMorgan Healthcare Leaders ETF) and RYHIX (Health Care Fund) share a meaningful slice of their top holdings — about 64% by weight.

But RYHIX is far broader, holding 135 positions to 61 for JDOC, so beyond the top names it adds exposure JDOC doesn't have.

JDOC is cheaper at 0.65% vs 1.38% — a difference of $73 a year per $10,000 invested.

Over one year, JDOC returned +14.9% vs +14.4% for RYHIX.

Updated Nov 19, 2026

JDOC vs RYHIX side by side

JDOCRYHIX
TypeETFMutual fund
Fund familyJ.P. MorganGuggenheim
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.65%1.38%
Annual cost per $10k$65$138
10-yr cost on $10k (prospectus)$810$1,709
Max front loadNone—
12b-1 fee—0%
1-yr return+14.9%+14.4%
5-yr return (annualized)—+5.1%
10-yr return (annualized)—+7.9%
Best quarter+11.3%+18.7%
Worst quarter−11.9%−14.4%
Net assets (fund)$9.1M$19.4M
Number of holdings61135
Portfolio turnover92%244%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearJDOCRYHIXDifference
2025+14.9%+14.4%+0.5%
2024−0.6%+0.6%−1.2%

Source: Fund prospectus bar charts

Holdings overlap

15 of JDOC's top 25 holdings also appear in RYHIX's top 25.

Shared top holdings
HoldingJDOCRYHIX
AbbVie, Inc.7.85%2.52%
Eli Lilly & Co.7.76%3.63%
UnitedHealth Group, Inc.5.85%2.22%
Merck & Co., Inc.4.82%2.04%
Johnson & Johnson4.82%2.88%
Thermo Fisher Scientific, Inc.3.73%1.61%
Bristol-Myers Squibb Co.3.57%1.22%
Abbott Laboratories3.11%1.42%
CVS Health Corp.2.83%1.31%
Stryker Corp.2.23%1.21%
Danaher Corp.2.16%1.30%
Intuitive Surgical, Inc.1.93%1.31%
Edwards Lifesciences Corp.1.73%0.84%
Regeneron Pharmaceuticals, Inc.1.60%0.90%
Cardinal Health, Inc.1.51%0.86%

Source: SEC Form N-PORT

JDOC top 10

  1. AbbVie, Inc. — 7.85%
  2. Eli Lilly & Co. — 7.76%
  3. UnitedHealth Group, Inc. — 5.85%
  4. Merck & Co., Inc. — 4.82%
  5. Johnson & Johnson — 4.82%
  6. AstraZeneca plc — 3.76%
  7. Thermo Fisher Scientific, Inc. — 3.73%
  8. Bristol-Myers Squibb Co. — 3.57%
  9. Abbott Laboratories — 3.11%
  10. CVS Health Corp. — 2.83%

RYHIX top 10

  1. Eli Lilly & Company — 3.63%
  2. Johnson & Johnson — 2.88%
  3. Abbvie Inc — 2.52%
  4. Unitedhealth Group Inc — 2.22%
  5. Merck & Company Inc — 2.04%
  6. Thermo Fisher Scientific Inc — 1.61%
  7. Amgen Inc — 1.56%
  8. Abbott Laboratories — 1.42%
  9. Gilead Sciences Inc — 1.39%
  10. Vertex Pharmaceuticals Inc — 1.34%

FAQ

What is the difference between JDOC and RYHIX?
JDOC (JPMorgan Healthcare Leaders ETF) and RYHIX (Health Care Fund) share a meaningful slice of their top holdings — about 64% by weight. But RYHIX is far broader, holding 135 positions to 61 for JDOC, so beyond the top names it adds exposure JDOC doesn't have.
Which is cheaper, JDOC or RYHIX?
JDOC has the lower expense ratio (0.65%).
Should I own both JDOC and RYHIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.